Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Intravenous Fosaprepitant and Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Thoracicsurgery Patients: A Single-center, Randomized, Double-Blinded Clinical Study

NCT05881486 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT05881486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05881486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Intravenous Fosaprepitant and Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Thoracicsurgery Patients: A Single-center, Randomized, Double-Blinded Clinical Study
Lead sponsor
Qilu Hospital of Shandong University
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2023
Completion date
June 30, 2023
Enrollment
234 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia complication, postoperative nausea and vomiting, thoracic diseases